Xellar Biosystems: Series ADevelops 3D human tissue models for drug discovery and testing using Organ-on-a-Chip technologyOct 4, 2026RoundOSXellar BiosystemsCompany profile and funding historySourcesprnewswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeries A · AIBiotechUnited StatesEnterprise softwareHealthtechNorth AmericaSeries A